Wui Ling Chan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wui Ling Chan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Paul Ivor Dargan
Clinical Toxicology Guy's and St Thomas' NHS Foundation Trust London UK
2 shared publications David M Wood
Guy’s and St Thomas’ NHS Foundation Trust and King’s Health Partners
1 shared publicationDavid M. Wood
Clinical Toxicology, Guys and St Thomas’ NHS Foundation Trust, London, UK
1 shared publication- David Michael Wood
Clinical Toxicology, Guy’s and St Thomas’ NHS Foundation Trust and King’s Health Partners, London, UK
1 shared publication - Dilin Tang
Emergency Department, Tan Tock Seng Hospital, Emergency Department Level B1 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore
1 shared publication - Dong Haur Phua
Emergency Department, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433
1 shared publication
Latest Publications
- 3 November 2020
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 87 (4) , 1660-1667
Prescription medicine misuse in the Asia–Pacific region: An evolving issue?
Prescription medicine misuse, especially misuse of opioids has become a major public healthcare issue in many developed countries such as the USA and Australia where this is associated with significant morbidity (Emergency Department visits due to acute toxicity) and mortality. In this review, we looked at the available data obtained from peer‐reviewed articles and population surveys to gain an insight into the current situation in the Asia–Pacific region. There is currently limited information available, but data from subpopulation surveys in a number of countries suggests that prescription medicine misuse is likely to be an issue of concern from a public health perspective in the Asia–Pacific region. The available data suggest that misuse prevalence rates and the medicines that are commonly misused are similar to countries such as the USA and UK. Further studies are required to determine the overall prevalence of misuse, the harms associated with this and the sources of drugs being misused so that appropriate interventions can be implemented to tackle issues related to prescription medicine misuse in this region.
- 3 November 2020
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 87 (4) , 1660-1667
Prescription medicine misuse in the Asia–Pacific region: An evolving issue?
Prescription medicine misuse, especially misuse of opioids has become a major public healthcare issue in many developed countries such as the USA and Australia where this is associated with significant morbidity (Emergency Department visits due to acute toxicity) and mortality. In this review, we looked at the available data obtained from peer‐reviewed articles and population surveys to gain an insight into the current situation in the Asia–Pacific region. There is currently limited information available, but data from subpopulation surveys in a number of countries suggests that prescription medicine misuse is likely to be an issue of concern from a public health perspective in the Asia–Pacific region. The available data suggest that misuse prevalence rates and the medicines that are commonly misused are similar to countries such as the USA and UK. Further studies are required to determine the overall prevalence of misuse, the harms associated with this and the sources of drugs being misused so that appropriate interventions can be implemented to tackle issues related to prescription medicine misuse in this region.
- Open Access
- 16 November 2018
- Published by Springer Nature in International Journal of Emergency Medicine
- Vol. 11 (1) , 48
Performance of an emergency department observation unit protocol in reducing length of stay for acetaminophen overdose: a retrospective study
Acetaminophen is one of the most common causes of poisoning among developed countries. The emergency department observation unit (EDOU) has been increasingly used in the management of various conditions to reduce hospitalisation but its efficacy in not well studied in management of poisoned patients. In this study, we aim to study the effectiveness of our EDOU in the management of acetaminophen overdosed patients. Medical records of patients admitted from the emergency department from 2012 to 2016 for acetaminophen overdose were reviewed. One hundred ninety-five patients presenting with acetaminophen overdose were admitted to the EDOU while 184 were admitted to the general ward. Of these, 27 patients admitted to EDOU did not meet the admission criteria for it while 71 patients who met EDOU criteria were admitted to the ward instead. For patients who fulfilled EDOU admission criteria, median length of stay for EDOU patients was 23 h (IQR 19–24) while that for those admitted to the ward was 66 h (IQR 62.5–88.3). The EDOU is a safe alternative to hospitalisation for patients presenting with acetaminophen poisoning. It is also associated with a shorter length of stay for such patients. Further studies need to be done to assess the cost-effectiveness of EDOU for management of patients presenting with acetaminophen overdose.
- 16 November 2018
- Published by Springer Nature in International Journal of Emergency Medicine
- Vol. 11 (1) , 48
Open AccessPerformance of an emergency department observation unit protocol in reducing length of stay for acetaminophen overdose: a retrospective study
Acetaminophen is one of the most common causes of poisoning among developed countries. The emergency department observation unit (EDOU) has been increasingly used in the management of various conditions to reduce hospitalisation but its efficacy in not well studied in management of poisoned patients. In this study, we aim to study the effectiveness of our EDOU in the management of acetaminophen overdosed patients. Medical records of patients admitted from the emergency department from 2012 to 2016 for acetaminophen overdose were reviewed. One hundred ninety-five patients presenting with acetaminophen overdose were admitted to the EDOU while 184 were admitted to the general ward. Of these, 27 patients admitted to EDOU did not meet the admission criteria for it while 71 patients who met EDOU criteria were admitted to the ward instead. For patients who fulfilled EDOU admission criteria, median length of stay for EDOU patients was 23 h (IQR 19–24) while that for those admitted to the ward was 66 h (IQR 62.5–88.3). The EDOU is a safe alternative to hospitalisation for patients presenting with acetaminophen poisoning. It is also associated with a shorter length of stay for such patients. Further studies need to be done to assess the cost-effectiveness of EDOU for management of patients presenting with acetaminophen overdose.
- 20 January 2016
- Published by Taylor & Francis in Journal of Substance Use
- Vol. 21 (5) , 495-500
Misuse of prescription and over-the-counter medicines in South London nightclubs
Objectives. There is currently little research on the extent of prescription and over-the-counter (OTC) medicines misuse in the United Kingdom. The objectives of this study were to determine the prevalence of OTC/prescription medicine misuse in the South London nightclub community and to look at the sources of supply. Methods. Individuals attending nightclubs in South London catering for, but not exclusively for, men who have sex with men (MSM) were surveyed about their use of recreational drugs, prescription, and OTC medicines and where they obtained these medications. Results. In total, 313 individuals were surveyed: 282 (90.1%) were male and 248 (79.2%) were MSM; 113 (36.1%) had misused at least one medicine in their lifetime and were more likely to have lifetime use of a recreational drug (OR 9.74, 95% CI 1.27–74.44). Diazepam (25.2%) and Z-drugs (zolpidem, zopiclone, zaleplon) (16.3%) were the most commonly misused medicines. The sources were friends (32.9%), dealers (15.7%), primary care doctors (13.7%), Internet purchases (10.9%), and overseas (7.3%). Conclusion. OTC and prescription medicines misuse is common among nightclub attendees in South London with these medicines coming from numerous sources. Further work is needed to determine the extent of this problem and the various forms of drug diversion.
- 20 January 2016
- Published by Taylor & Francis in Journal of Substance Use
- Vol. 21 (5) , 495-500
Misuse of prescription and over-the-counter medicines in South London nightclubs
Objectives. There is currently little research on the extent of prescription and over-the-counter (OTC) medicines misuse in the United Kingdom. The objectives of this study were to determine the prevalence of OTC/prescription medicine misuse in the South London nightclub community and to look at the sources of supply. Methods. Individuals attending nightclubs in South London catering for, but not exclusively for, men who have sex with men (MSM) were surveyed about their use of recreational drugs, prescription, and OTC medicines and where they obtained these medications. Results. In total, 313 individuals were surveyed: 282 (90.1%) were male and 248 (79.2%) were MSM; 113 (36.1%) had misused at least one medicine in their lifetime and were more likely to have lifetime use of a recreational drug (OR 9.74, 95% CI 1.27–74.44). Diazepam (25.2%) and Z-drugs (zolpidem, zopiclone, zaleplon) (16.3%) were the most commonly misused medicines. The sources were friends (32.9%), dealers (15.7%), primary care doctors (13.7%), Internet purchases (10.9%), and overseas (7.3%). Conclusion. OTC and prescription medicines misuse is common among nightclub attendees in South London with these medicines coming from numerous sources. Further work is needed to determine the extent of this problem and the various forms of drug diversion.
- 4 June 2013
- Published by Springer Nature in Journal of Medical Toxicology
- Vol. 9 (3) , 278-281
Acute Psychosis Associated with Recreational Use of Benzofuran 6-(2-Aminopropyl)Benzofuran (6-APB) and Cannabis
There is evidence from around Europe of the availability and use of 6-(2-aminopropyl)benzofuran (6-APB) as a recreational drug. However, there is currently limited information on the acute toxicity of this compound. We describe here a case of acute toxicity associated with recreational use of legal high (6-APB) and cannabis, in which the comprehensive toxicological analysis confirmed the presence of a significant amount of 6-APB together with metabolites of both tetrahydrocannabinol and the synthetic cannabinoid receptor agonist (JWH-122). A 21-year-old gentleman with no previous medical and psychiatric history was brought to the emergency department (ED) after he had developed agitation and paranoid behaviour following the use of 6-APB purchased over the Internet. There was no obvious medical cause for his acute psychosis. He required diazepam to control his agitation and was subsequently transferred to a psychiatric hospital for ongoing management of his psychosis. Toxicological screening of a urine sample collected after presentation to the ED detected 6-APB, with an estimated urinary concentration of 2,000 ng/ml; other drugs were also detected, but at lower concentrations including metabolites of the synthetic cannabinoid receptor agonist JWH-122 and tetrahydrocannabinol. This is the first case of analytically confirmed acute toxicity associated with the detection of 6-APB which will provide some information on acute toxicity of this drug to help clinicians with the management of such patients and legislative authorities in their consideration for the need of its control.
- 4 June 2013
- Published by Springer Nature in Journal of Medical Toxicology
- Vol. 9 (3) , 278-281
Acute Psychosis Associated with Recreational Use of Benzofuran 6-(2-Aminopropyl)Benzofuran (6-APB) and Cannabis
There is evidence from around Europe of the availability and use of 6-(2-aminopropyl)benzofuran (6-APB) as a recreational drug. However, there is currently limited information on the acute toxicity of this compound. We describe here a case of acute toxicity associated with recreational use of legal high (6-APB) and cannabis, in which the comprehensive toxicological analysis confirmed the presence of a significant amount of 6-APB together with metabolites of both tetrahydrocannabinol and the synthetic cannabinoid receptor agonist (JWH-122). A 21-year-old gentleman with no previous medical and psychiatric history was brought to the emergency department (ED) after he had developed agitation and paranoid behaviour following the use of 6-APB purchased over the Internet. There was no obvious medical cause for his acute psychosis. He required diazepam to control his agitation and was subsequently transferred to a psychiatric hospital for ongoing management of his psychosis. Toxicological screening of a urine sample collected after presentation to the ED detected 6-APB, with an estimated urinary concentration of 2,000 ng/ml; other drugs were also detected, but at lower concentrations including metabolites of the synthetic cannabinoid receptor agonist JWH-122 and tetrahydrocannabinol. This is the first case of analytically confirmed acute toxicity associated with the detection of 6-APB which will provide some information on acute toxicity of this drug to help clinicians with the management of such patients and legislative authorities in their consideration for the need of its control.